Eric Daniels

Corporate Officer/Principal at KIORA PHARMACEUTICALS, INC.

Net worth: 42 288 $ as of 2024-04-29

51 year

18 connections

Consumer Services

Health Technology

Commercial Services

Active connections

Name	Gender	Age	Linked companies	Collaboration
Brian Strem	M	44	KIORA PHARMACEUTICALS, INC. Bayon Therapeutics, Inc. Okogen, Inc. Okogen, Inc. Miscellaneous Commercial ServicesCommercial Services Okogen, Inc. engages in the development of clinical theraphies to serve the needs of adult and children with ocular infections. Its lead candidate, OKG-0301, is a ribonuclease which targets degradation of specific tRNA and miRNA, which leads to inhibiting protein synthesis. It stops viral replication and shortens the duration of infection. The company was founded on July 1, 2016 and is headquartered in Encinitas, CA.	3 years
Praveen Tyle	M	64	KIORA PHARMACEUTICALS, INC.	16 years
Joshua Moriarty	M	-	Okogen, Inc. Okogen, Inc. Miscellaneous Commercial ServicesCommercial Services Okogen, Inc. engages in the development of clinical theraphies to serve the needs of adult and children with ocular infections. Its lead candidate, OKG-0301, is a ribonuclease which targets degradation of specific tRNA and miRNA, which leads to inhibiting protein synthesis. It stops viral replication and shortens the duration of infection. The company was founded on July 1, 2016 and is headquartered in Encinitas, CA.	-
Melissa Tosca	F	44	KIORA PHARMACEUTICALS, INC.	2 years
Bradford Conlan	M	-	Okogen, Inc. Okogen, Inc. Miscellaneous Commercial ServicesCommercial Services Okogen, Inc. engages in the development of clinical theraphies to serve the needs of adult and children with ocular infections. Its lead candidate, OKG-0301, is a ribonuclease which targets degradation of specific tRNA and miRNA, which leads to inhibiting protein synthesis. It stops viral replication and shortens the duration of infection. The company was founded on July 1, 2016 and is headquartered in Encinitas, CA.	-
Carmine Stengone	M	48	KIORA PHARMACEUTICALS, INC.	1 years
Aron Shapiro	M	46	KIORA PHARMACEUTICALS, INC.	3 years
Kenneth Gayron	M	54	KIORA PHARMACEUTICALS, INC.	3 years
David Hollander	M	50	KIORA PHARMACEUTICALS, INC.	3 years
Erin Parsons	F	48	KIORA PHARMACEUTICALS, INC.	2 years
Stefan Sperl	M	-	KIORA PHARMACEUTICALS, INC.	-

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
Stephen From	M	60	KIORA PHARMACEUTICALS, INC.	17 years
Paul Chaney	M	66	KIORA PHARMACEUTICALS, INC.	16 years
Franz Obermayr	M	55	KIORA PHARMACEUTICALS, INC.	1 years
Sarah Romano	F	44	KIORA PHARMACEUTICALS, INC.	6 years
Susan Drexler	F	54	KIORA PHARMACEUTICALS, INC.	-
Michael Meluzio	M	-	KIORA PHARMACEUTICALS, INC.	-
Angela Dentiste	F	-	KIORA PHARMACEUTICALS, INC.	-

Statistics

Country	Connections	% of total
United States	18	100.00%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections